The aim of this study was to compare the effectiveness and safety of topical tretinoin cream 0.05% alone against combination with oral isotretinoin (0.5 mg/kg/day) for treatment of plane warts.
This study included 39 patients divided into two groups. Treatment was given for three months duration. Patients were followed-up for further three months to assess the recurrence rate. Combination treatment led to a faster resolution and a higher percentage of complete response. It presents a promising effective alternative option for treatment of plane warts.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
39
Topical tretinoin cream 0.05% applied once daily at night
Topical tretinoin cream 0.05% once daily at night + oral isotretinoin capsule in the dose of 0.5 mg/kg/day
Tishreen University- Faculty of Medicine
Latakia, Latakia Governorate, Syria
Response Rate, as Measured by the Reduction in Number of Lesions at Week 4
The response is assessed according to the decrease in number of lesions as followed: complete response (total clearance of warts), partial response (decease in the number of lesion ≥ 50%), no response (decrease in the number of lesion \<50% or no clearance).
Time frame: Week 4
Response Rate, as Measured by the Reduction in Number of Lesions at Week 8
The response is assessed according to the decrease in number of lesions as followed: complete response (total clearance of warts), partial response (decease in the number of lesion ≥ 50%), no response (decrease in the number of lesion \<50% or no clearance).
Time frame: Week 8
Response Rate, as Measured by the Reduction in Number of Lesions at Week 12
The response is assessed according to the decrease in number of lesions as followed: complete response (total clearance of warts), partial response (decease in the number of lesion ≥ 50%), no response (decrease in the number of lesion \<50% or no clearance).
Time frame: Week 12
Safety, as Measured by the Number of Patients With at Least one Adverse Effect
The adverse effects are defined as unwanted effects related directly to the drug
Time frame: week 12
Recurrence Rate, as Measured by the Number of Patients who Have Recurrent Lesions After 12 Weeks of Termination of Therapy
The recurrence is defined as reappearance of lesions at the same locations after complete response
Time frame: 12 weeks after termination of therapy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.